OCUGEN, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
OCUGEN, INC. (OCGN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 9.64 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 1.59M shares, a 53.94% increase year-over-year.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 8.05M shares, a 22.83% increase year-over-year.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 768.03K shares, a 751.75% increase year-over-year.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 1.96M shares, a 543.70% increase year-over-year.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 10.31M shares, a 154.23% increase from fiscal 2024.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 4.06M shares, a 19.57% decline from fiscal 2023.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 5.04M shares.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 4.31M shares, a 373.25% increase from fiscal 2017.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 1.59M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 9.64M shares 10-Q · filed 2026-08-06 | 10.41M shares derived: sum of 3 quarters · filed 2026-08-06 | 12.36M shares derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | 8.05M shares 10-Q · filed 2026-05-08 | 8.82M shares derived: sum of 2 quarters · filed 2026-05-08 | 10.78M shares derived: sum of 3 quarters · filed 2026-05-08 | 11.81M shares derived: sum of 4 quarters · filed 2026-05-08 | |
| 2026-01-02 | 3.12M shares 10-Q · filed 2026-08-06 | ||||
| 2025-12-31 | 768.03K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 2.73M shares derived: sum of 2 quarters · filed 2026-03-04 | 3.76M shares derived: sum of 3 quarters · filed 2026-03-04 | 10.31M shares 10-K · filed 2026-03-04 | |
| 2025-09-30 | 1.96M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 2.99M shares derived: sum of 2 quarters · filed 2025-11-05 | 9.54M shares 10-Q · filed 2025-11-05 | 9.63M shares derived: sum of 4 quarters · filed 2025-11-05 | |
| 2025-06-30 | 1.03M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | 7.59M shares 10-Q · filed 2025-08-04 | 7.68M shares derived: sum of 3 quarters · filed 2025-08-04 | 7.98M shares derived: sum of 4 quarters · filed 2025-08-04 | |
| 2025-03-31 | 6.55M shares 10-Q · filed 2025-05-09 | 6.64M shares derived: sum of 2 quarters · filed 2025-05-09 | 6.95M shares derived: sum of 3 quarters · filed 2025-05-09 | 7.98M shares derived: sum of 4 quarters · filed 2025-05-09 | |
| 2024-12-31 | 90.17K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | 394.26K shares derived: sum of 2 quarters · filed 2025-03-05 | 1.42M shares derived: sum of 3 quarters · filed 2025-03-05 | 4.06M shares 10-K · filed 2025-03-05 | |
| 2024-09-30 | 304.09K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 1.33M shares derived: sum of 2 quarters · filed 2024-11-14 | 3.97M shares 10-Q · filed 2024-11-14 | 4.16M shares derived: sum of 4 quarters · filed 2024-11-14 | |
| 2024-06-30 | 1.03M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 3.66M shares 10-Q · filed 2024-08-08 | 3.85M shares derived: sum of 3 quarters · filed 2024-08-08 | 3.98M shares derived: sum of 4 quarters · filed 2024-08-08 | |
| 2024-03-31 | 2.63M shares 10-Q · filed 2024-05-14 | 2.82M shares derived: sum of 2 quarters · filed 2024-05-14 | 2.95M shares derived: sum of 3 quarters · filed 2024-05-14 | 3.97M shares derived: sum of 4 quarters · filed 2024-05-14 | |
| 2023-12-31 | 191.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | 319.73K shares derived: sum of 2 quarters · filed 2024-04-16 | 1.34M shares derived: sum of 3 quarters · filed 2024-04-16 | 5.04M shares 10-K · filed 2024-04-16 | |
| 2023-09-30 | 128.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 1.15M shares derived: sum of 2 quarters · filed 2023-11-09 | 4.85M shares 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | 1.02M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | 4.72M shares 10-Q · filed 2023-08-21 | |||
| 2023-03-31 | 3.70M shares 10-Q · filed 2023-05-05 | ||||
| 2022-09-30 | 329.22K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 1.49M shares derived: sum of 2 quarters · filed 2022-11-08 | 5.81M shares 10-Q · filed 2022-11-08 | ||
| 2022-06-30 | 1.16M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | 5.48M shares 10-Q · filed 2022-08-05 | |||
| 2022-03-31 | 4.32M shares 10-Q · filed 2022-05-06 | ||||
| 2021-09-30 | 372.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 7.47M shares 10-Q · filed 2021-11-09 | |||
| 2021-06-30 | 7.10M shares 10-Q · filed 2021-08-06 | ||||
| 2018-12-31 | 2.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | 3.16M shares derived: sum of 2 quarters · filed 2019-03-22 | 3.37M shares derived: sum of 3 quarters · filed 2019-03-22 | 4.31M shares 10-K · filed 2019-03-22 | |
| 2018-09-30 | 380.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 585.20K shares derived: sum of 2 quarters · filed 2018-11-08 | 1.53M shares 10-Q · filed 2018-11-08 | 1.58M shares derived: sum of 4 quarters · filed 2018-11-08 | |
| 2018-06-30 | 204.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 1.15M shares 10-Q · filed 2018-08-09 | 1.20M shares derived: sum of 3 quarters · filed 2018-08-09 | 1.22M shares derived: sum of 4 quarters · filed 2018-08-09 | |
| 2018-03-31 | 944.95K shares 10-Q · filed 2018-05-10 | 995.90K shares derived: sum of 2 quarters · filed 2018-05-10 | 1.02M shares derived: sum of 3 quarters · filed 2018-05-10 | 1.37M shares derived: sum of 4 quarters · filed 2018-05-10 | |
| 2017-12-31 | 50.95K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | 70.95K shares derived: sum of 2 quarters · filed 2018-03-15 | 424.50K shares derived: sum of 3 quarters · filed 2018-03-15 | 910.95K shares 10-K · filed 2018-03-15 | |
| 2017-09-30 | 20.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 373.55K shares derived: sum of 2 quarters · filed 2017-11-09 | 860.00K shares 10-Q · filed 2017-11-09 | 1.11M shares derived: sum of 4 quarters · filed 2017-11-09 | |
| 2017-06-30 | 353.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | 840.00K shares 10-Q · filed 2017-08-10 | 1.09M shares derived: sum of 3 quarters · filed 2017-08-10 | 1.09M shares derived: sum of 4 quarters · filed 2017-08-10 | |
| 2017-03-31 | 486.45K shares 10-Q · filed 2017-05-11 | 735.85K shares derived: sum of 2 quarters · filed 2017-05-11 | 739.35K shares derived: sum of 3 quarters · filed 2017-05-11 | 756.65K shares derived: sum of 4 quarters · filed 2017-05-11 | |
| 2016-12-31 | 249.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 252.90K shares derived: sum of 2 quarters · filed 2017-03-16 | 270.20K shares derived: sum of 3 quarters · filed 2017-03-16 | 464.24K shares 10-K · filed 2017-03-16 | |
| 2016-09-30 | 3.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 20.80K shares derived: sum of 2 quarters · filed 2016-11-10 | 214.84K shares 10-Q · filed 2016-11-10 | 265.84K shares derived: sum of 4 quarters · filed 2016-11-10 | |
| 2016-06-30 | 17.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | 211.34K shares 10-Q · filed 2016-08-11 | 262.34K shares derived: sum of 3 quarters · filed 2016-08-11 | 617.24K shares derived: sum of 4 quarters · filed 2016-08-11 | |
| 2016-03-31 | 194.04K shares 10-Q · filed 2016-05-12 | 245.04K shares derived: sum of 2 quarters · filed 2016-05-12 | 599.94K shares derived: sum of 3 quarters · filed 2016-05-12 | 719.71K shares derived: sum of 4 quarters · filed 2016-05-12 | |
| 2015-12-31 | 51.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | 405.90K shares derived: sum of 2 quarters · filed 2016-03-10 | 525.67K shares derived: sum of 3 quarters · filed 2016-03-10 | 914.72K shares 10-K · filed 2016-03-10 | |
| 2015-09-30 | 354.90K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 474.67K shares derived: sum of 2 quarters · filed 2015-11-12 | 863.72K shares 10-Q · filed 2015-11-12 | ||
| 2015-06-30 | 119.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | 508.82K shares 10-Q · filed 2015-08-12 | |||
| 2015-03-31 | 389.05K shares 10-Q · filed 2015-05-14 | ||||
| 2014-03-31 | 0.00 shares 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |